We found that different AD tau fractions displayed different properties in truncation, hyperphosphorylation, resistance to proteinase K, capturing normal tau in vitro and seeding tau aggregation in cultured cells and in vivo. The gene discussed is MAPT; the disease is Alzheimer disease.